Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
12.310
-0.640-4.94%
Close 08/11 16:00 ET
12.31000.00%
Post Mkt Price 08/11 16:25 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
13.200
Open
12.610
Turnover
250.95K
Low
12.030
Pre Close
12.950
Volume
20.22K
Market Cap
411.49M
P/E(TTM)
Loss
52wk High
20.950
Shares
33.43M
P/E(Static)
Loss
52wk Low
7.900
Float Cap
166.55M
Bid/Ask %
81.82%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.76
Historical Low
7.900
Dividend TTM
--
Div Yield TTM
--
P/B
1.36
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.15%
Amplitude
9.04%
Avg Price
12.410
Lot Size
1
Float Cap
166.55M
Bid/Ask %
81.82%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.76
Historical Low
7.900
Dividend TTM
--
P/B
1.36
Dividend LFY
--
Turnover Ratio
0.15%
Amplitude
9.04%
Avg Price
12.410
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top